mhurhangee/ep-ind-claims huggingface dataset:
A self-healing platform unit for pressure and analyte sensing, the platform unit comprising: a self-healing substrate comprising a dynamically crosslinked polymer comprising polymeric chains, comprising poly(urea-urethane), and crosslinking bridges; at least one self-healing electrode comprising a non-crosslinked polymer and metal microparticles dispersed therein, wherein the at least one self-healing electrode is deposited on the substrate; and at least one sensor comprising metal nanoparticles capped with an organic coating, wherein the at least one sensor is deposited on the substrate and is in electric contact with the at least one self-healing electrode. a self-healing substrate comprising a dynamically crosslinked polymer comprising polymeric chains, comprising poly(urea-urethane), and crosslinking bridges; at least one self-healing electrode comprising a non-crosslinked polymer and metal microparticles dispersed therein, wherein the at least one self-healing electrode is deposited on the substrate; and at least one sensor comprising metal nanoparticles capped with an organic coating, wherein the at least one sensor is deposited on the substrate and is in electric contact with the at least one self-healing electrode.
A method of operating a multiple energy source of a transport refrigeration unit for refrigeration of a cargo compartment, the method being characterised by comprising: driving a condenser fan by a condenser fan motor to facilitate air flow across a condenser of the transport refrigeration unit; determining if the transport refrigeration unit is idle; if the transport refrigeration unit is determined as being idle electrically switching the condenser fan motor from receiving electrical power to a battery charging circuit; and subsequently back-driving the condenser fan motor via wind blowing through the condenser fan and generating electrical power by the condenser fan motor to charge a battery of the transport refrigeration unit via the battery charging circuit. driving a condenser fan by a condenser fan motor to facilitate air flow across a condenser of the transport refrigeration unit; determining if the transport refrigeration unit is idle; if the transport refrigeration unit is determined as being idle electrically switching the condenser fan motor from receiving electrical power to a battery charging circuit; and subsequently back-driving the condenser fan motor via wind blowing through the condenser fan and generating electrical power by the condenser fan motor to charge a battery of the transport refrigeration unit via the battery charging circuit.
Diagnostic test tape for liquid samples, in particular body fluids, comprising a flexible transport tape that is wound onto or can be wound onto a spool (62, 64) and a plurality of test fields applied to the transport tape that are distributed in the longitudinal direction of the tape, said test fields comprising a detection layer and a spreading net spanning the detection layer for a two-dimensional uptake of liquid sample, wherein the spreading net is formed from a lattice-like fabric comprising fabric threads that cross at right angles (28, 30), characterized in that the fabric is oriented obliquely to the transport tape such that all fabric threads (28, 30) run obliquely to the longitudinal direction of the tape.
A method for the production of a population of galactoengineered trastuzumab, comprising the steps of a) recombinantly producing trastuzumab in a host cell, which comprises nucleic acid molecules encoding trastuzumab, to obtain a population of trastuzumab, b) isolating said population of trastuzumab, c) enzymatically treating said population of trastuzumab with galactosyltransferase to obtain a population of galactoengineered trastuzumab, which comprises a relative frequency of 80 - 95 % of Fc bi-galactosylated antibodies and a relative frequency of 7 - 16 % of Fc afucosylated antibodies; and subsequent separation of the population of said galactoengineered trastuzumab from said enzyme. a) recombinantly producing trastuzumab in a host cell, which comprises nucleic acid molecules encoding trastuzumab, to obtain a population of trastuzumab, b) isolating said population of trastuzumab, c) enzymatically treating said population of trastuzumab with galactosyltransferase to obtain a population of galactoengineered trastuzumab, which comprises a relative frequency of 80 - 95 % of Fc bi-galactosylated antibodies and a relative frequency of 7 - 16 % of Fc afucosylated antibodies; and subsequent separation of the population of said galactoengineered trastuzumab from said enzyme.
Actuating mechanism for a lifting or lifting-sliding wing, having a rotatably mounted gear nut into which a polygon can be inserted and which is connected in an articulated manner to a toggle lever which drives a displaceable drive rod, wherein the gear nut is rotatable between an initial position with lowered wing into an end position with raised wing, and the toggle lever, when the gear nut is rotated, passes through a dead center at which the wing is arranged in the maximum raised position, characterized in that a damping element is arranged on the toggle lever and, in the position of the toggle lever at the dead center, rests in a clamping manner against the polygon.
A device for cleaning the external auditory meatus, comprising a guide sleeve with a proximal outlet portion for partial insertion into the auditory meatus and an instrumentation rod which can be axially passed through the guide sleeve and which has, at a proximal end region, a cleaning apparatus with at least one cleaning means which runs circumferentially and expands elastically in the radial direction, characterized in that an inner cross-section of the proximal outlet portion is smaller than an outer cross-section of the cleaning means in a radially expanded state, wherein the at least one cleaning means can be arranged within the proximal outlet portion in a radially compressed state in which the cleaning means is bent towards the longitudinal axis of the instrumentation rod in the distal direction, such that the at least one cleaning means becomes upright while changing to the radially expanded state when it moves out of the proximal outlet portion in the proximal direction.
A testing device for detecting a pressing force of a vehicle side window adjoining a window seal arranged on a bodywork, characterized by - a central unit comprising a power supply, an evaluation unit and a display unit for displaying the determined pressing force, and - a pressure-measuring film that can be arranged in a removable manner on the vehicle side window in the region of the window seal and that is connected to the evaluation unit of the central unit, wherein the pressure-measuring film comprises a positioning element for removable arrangement on the vehicle side window. - a central unit comprising a power supply, an evaluation unit and a display unit for displaying the determined pressing force, and - a pressure-measuring film that can be arranged in a removable manner on the vehicle side window in the region of the window seal and that is connected to the evaluation unit of the central unit, wherein the pressure-measuring film comprises a positioning element for removable arrangement on the vehicle side window.
A composite semipermeable membrane having a separating functional polyamide layer being provided on a porous support membrane formed on a base material, wherein azo compounds are retained in parts excluding the base material in the semipermeable membrane, characterized in that the content of the azo compounds retained in parts excluding the base material in the semipermeable membrane calculated according to the following equation is in the range of 0.05% by weight to 0.5% by weight, and the separating functional layer has a yellow index of 10 to 40: azo compound content in parts excluding base material in semipermeable membrane = 100 × azo compound weight in terms of chrysoidine / dried membrane weight.
An anhydrous topical composition comprising salmon oil in an amount ranging from 40% to 60% by weight, palm olein, preferably red palm olein or red palm super olein, present in an amount ranging from 10% to 20% by weight, C8 /C10 fatty acid in an amount ranging from 0.5% to 4% by weight, C8/C10 triglyceride present in an amount ranging from 25% to 35% by weight, cetyl ester ranging from 0.5 % to 2% by weight and monolaurin ranging from 0.5% to 2% by weight, wherein the weight ratio of the sum of the saturated compounds in the salmon oil, palm olein and C8/C10 triglyceride to the sum of the mono-unsaturated compounds in the salmon oil, palm olein and C8/C10 triglyceride ranges from 1.8 to 2.2, and the weight ratio of C8/C10 triglyceride to C8/C10 fatty acid ranges from 10:1 to 25:1, wherein the sum of the dry weight percent of all of the components present is equal to 100%.
A handheld applicator for treating a skin by means of microwave radiation, comprising an applicator housing, and a microwave emitter configured to emit microwave radiation for treating tissue in a target area, characterized by an actuator assembly configured to move the microwave emitter relative to the applicator housing whilst emitting microwave radiation for increasing uniformity of tissue treatment in the target area. an applicator housing, and a microwave emitter configured to emit microwave radiation for treating tissue in a target area, characterized by an actuator assembly configured to move the microwave emitter relative to the applicator housing whilst emitting microwave radiation for increasing uniformity of tissue treatment in the target area.
A computer-implemented method (200, 600) of operating a computed tomography scanner comprising a subject support configured to move linearly and a rotating portion that mounts a radiation outputting system (112, 400) and controllably rotates around the subject support, the computer-implemented method comprising performing a scanning procedure comprising: controlling the radiation outputting system to output radiation during an imaging phase of the scanning procedure; controlling the subject support to move linearly, the linear movement of the subject support during the imaging phase of the scanning procedure including at least one acceleration (t a) or deceleration phase (t d); and controlling one or more parameters of the computed tomography scanner responsive to the speed of the subject support, wherein the one or more parameters comprises at least a beam width (w) of the radiation output by the radiation outputting system, and characterized in that the step of controlling one or more parameters comprises controlling the beam width proportionally to the speed of the subject support. controlling the radiation outputting system to output radiation during an imaging phase of the scanning procedure; controlling the subject support to move linearly, the linear movement of the subject support during the imaging phase of the scanning procedure including at least one acceleration (t a) or deceleration phase (t d); and controlling one or more parameters of the computed tomography scanner responsive to the speed of the subject support, wherein the one or more parameters comprises at least a beam width (w) of the radiation output by the radiation outputting system, and characterized in that the step of controlling one or more parameters comprises controlling the beam width proportionally to the speed of the subject support.
A wiring support structure (1; 1a) comprising: a column portion fixed to or provided integrally with an installation object in which wiring is installed, and provided so as to project from the installation object; a wiring support portion having a wiring arrangement portion that is arrangeable so as to extend along the installation object and in which the wiring is arranged in an extending direction of the wiring arrangement portion, the wiring support portion being supported by the column portion in a state where the wiring support portion is separate from the installation object; and an attachment portion for attaching the wiring to the wiring arrangement portion, wherein the wiring support portion has a plate portion that is formed in a plate shape having a predetermined width and is arranged so as to face the installation object, wherein the wiring support portion has a wall portion arranged so as to extend along the installation object, and at least one of one surface and the other surface of the wall portion is provided as the wiring arrangement portion, characterized in that the wiring support portion has a groove portion serving as the wiring arrangement portion, and wherein the groove portion is formed on a wall surface of the wall portion on a side opposite to the plate portion side. a column portion fixed to or provided integrally with an installation object in which wiring is installed, and provided so as to project from the installation object; a wiring support portion having a wiring arrangement portion that is arrangeable so as to extend along the installation object and in which the wiring is arranged in an extending direction of the wiring arrangement portion, the wiring support portion being supported by the column portion in a state where the wiring support portion is separate from the installation object; and an attachment portion for attaching the wiring to the wiring arrangement portion,
A hybrid polymer composite fiber comprising: graphene oxide or chemically reduced graphene having acid functional groups on the surface thereof; and carbon nanotubes modified with a surfactant having a hydrophilic sulfonic acid group (SO 3 -), wherein, the graphene oxide or the chemically reduced graphene and the carbon nanotubes are self-aligned through hydrogen bonding. graphene oxide or chemically reduced graphene having acid functional groups on the surface thereof; and carbon nanotubes modified with a surfactant having a hydrophilic sulfonic acid group (SO 3 -), wherein, the graphene oxide or the chemically reduced graphene and the carbon nanotubes are self-aligned through hydrogen bonding.
A solid composition for oral administration comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, wherein the amount of said salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid is at least 0.6 mmol; and wherein said GLP-1 agonist is semaglutide.
A head-mounted display, comprising: a housing being a portion of a front rigid body, where one or more display panels are mounted, the housing defining an enclosure having an aperture; a speaker positioned within the enclosure, the speaker having a back side facing an interior surface of the housing and a front side facing away from the interior surface of the housing, a back volume defined between at least a portion of the housing and the back side of the speaker for enhancing sound generated by the speaker; and a sound conduit having an end open to the enclosure and extending outside the housing through the aperture, the sound conduit having another end open toward a rear direction to transmit the sound generated by the speaker toward an ear of a user wearing the HMD; characterised in that the housing includes a body portion and a cover portion mounted to the body portion, the body portion defining the back volume and the cover portion defining the aperture. a housing being a portion of a front rigid body, where one or more display panels are mounted, the housing defining an enclosure having an aperture; a speaker positioned within the enclosure, the speaker having a back side facing an interior surface of the housing and a front side facing away from the interior surface of the housing, a back volume defined between at least a portion of the housing and the back side of the speaker for enhancing sound generated by the speaker; and a sound conduit having an end open to the enclosure and extending outside the housing through the aperture, the sound conduit having another end open toward a rear direction to transmit the sound generated by the speaker toward an ear of a user wearing the HMD; characterised in that the housing includes a body portion and a cover portion mounted to the body portion, the body portion defining the back volume and the cover portion defining the aperture.
Composition for use in tanning human skin wherein the composition comprises: 0.05 to 2.0 % Caffeine, 0.01 to 1.0 % Glycine, 0.001 to 0.2 % Hydrolyzed Citrus Aurantium Dulcis Fruit Extract; 0.05 to 0.5 % Sodium Lactate Methylsilanol and 0.05 to 3.0 % Mauritia Flexuosa Fruit Oil, and the remainder up to 100 % of usual dermatological or cosmetic auxiliaries, all percentages being % by weight and related to the total weight of the composition. 0.05 to 2.0 % Caffeine, 0.01 to 1.0 % Glycine, 0.001 to 0.2 % Hydrolyzed Citrus Aurantium Dulcis Fruit Extract; 0.05 to 0.5 % Sodium Lactate Methylsilanol and 0.05 to 3.0 % Mauritia Flexuosa Fruit Oil,
A user equipment, UE, the UE comprising: a transceiver; and a controller configured to: receive, from a base station, downlink control information, DCI, for scheduling of a physical uplink shared channel, PUSCH, over multiple subframes in an unlicensed band, wherein the DCI includes: information on a number of subframes for a PUSCH transmission, information on a timing offset for the PUSCH transmission, information on a hybrid automatic repeat request, HARQ, process number which applies to a first PUSCH transmission, and information on a new data indicator, NDI, indicating whether the PUSCH transmission is for a new data transport block, TB; perform a procedure to determine that a channel in the unlicensed band is available; and transmit the PUSCH based on the procedure and the DCI. a transceiver; and a controller configured to: receive, from a base station, downlink control information, DCI, for scheduling of a physical uplink shared channel, PUSCH, over multiple subframes in an unlicensed band, wherein the DCI includes: information on a number of subframes for a PUSCH transmission, information on a timing offset for the PUSCH transmission, information on a hybrid automatic repeat request, HARQ, process number which applies to a first PUSCH transmission, and information on a new data indicator, NDI, indicating whether the PUSCH transmission is for a new data transport block, TB; perform a procedure to determine that a channel in the unlicensed band is available; and transmit the PUSCH based on the procedure and the DCI. information on a number of subframes for a PUSCH transmission, information on a timing offset for the PUSCH transmission, information on a hybrid automatic repeat request, HARQ, process number which applies to a first PUSCH transmission, and information on a new data indicator, NDI, indicating whether the PUSCH transmission is for a new data transport block, TB; perform a procedure to determine that a channel in the unlicensed band is available; and transmit the PUSCH based on the procedure and the DCI.
An apparatus comprising: at least one processor and at least one memory including a computer program code, the at least one memory and the computer program code configured to, with the at least one processor, cause the apparatus at least to: control the transmission and reception of data on one or more carriers at an access node of a network utilizing a frame configuration for Time Division Duplexing in frames comprising sub frames, where multiple carriers utilized in the network are synchronized with each other, and wherein the frame configuration comprises a predetermined number of sub frames reserved for predetermined transmission directions in the network and flexible sub frames allocated dynamically and carrier specifically either in downlink or uplink direction. at least one processor and at least one memory including a computer program code, the at least one memory and the computer program code configured to, with the at least one processor, cause the apparatus at least to: control the transmission and reception of data on one or more carriers at an access node of a network utilizing a frame configuration for Time Division Duplexing in frames comprising sub frames, where multiple carriers utilized in the network are synchronized with each other, and wherein the frame configuration comprises a predetermined number of sub frames reserved for predetermined transmission directions in the network and flexible sub frames allocated dynamically and carrier specifically either in downlink or uplink direction. control the transmission and reception of data on one or more carriers at an access node of a network utilizing a frame configuration for Time Division Duplexing in frames comprising sub frames, where multiple carriers utilized in the network are synchronized with each other, and wherein the frame configuration comprises a predetermined number of sub frames reserved for predetermined transmission directions in the network and flexible sub frames allocated dynamically and carrier specifically either in downlink or uplink direction.
A method for determining a transport block size, comprising: determining, by a communications device, a type of an available resource element, RE, for data scheduling based on a quantity of available REs in one slot and one resource block, RB, wherein the available RE is used to carry data; determining, by the communications device according to a service type of the data scheduling, a scale factor corresponding to the type of the available RE, and multiplying the scale factor by a preset value, to obtain a transport block size of scheduled data; wherein the preset value is calculated based on a modulation scheme, a code rate, a quantity of transmission layers, and a first quantity of available REs, and the first quantity of available REs is determined based on a time-frequency resource for the scheduled data. determining, by a communications device, a type of an available resource element, RE, for data scheduling based on a quantity of available REs in one slot and one resource block, RB, wherein the available RE is used to carry data; determining, by the communications device according to a service type of the data scheduling, a scale factor corresponding to the type of the available RE, and multiplying the scale factor by a preset value, to obtain a transport block size of scheduled data; wherein the preset value is calculated based on a modulation scheme, a code rate, a quantity of transmission layers, and a first quantity of available REs, and the first quantity of available REs is determined based on a time-frequency resource for the scheduled data.